Acuta Capital Partners, LLC Rapt Therapeutics, Inc. Transaction History

Acuta Capital Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$17.99 - $40.02 $3.6 Million - $8.02 Million	-200,289 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$16.0 - $24.46 $148,976 - $227,747	-9,311 Reduced 4.44%	200,289 $4.45 Million
Q4 2020 Feb 16, 2021	SELL	$15.89 - $40.87 $483,056 - $1.24 Million	-30,400 Reduced 12.67%	209,600 $4.14 Million
Q3 2020 Nov 16, 2020	BUY	$21.6 - $37.5 $5.18 Million - $9 Million	240,000 New	240,000 $7.73 Million

104

27.1M

26.7K

2.4K

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $32M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

Get notified when there are updates to the investment portfolio of Acuta Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Acuta Capital Partners, LLC with notifications on news.